Sulfabenzamide NEW
| Price | $42 |
| Package | 5g |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Sulfabenzamide | CAS No.: 127-71-9 |
| Purity: 99.82% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Sulfabenzamide |
| Description | Sulfabenzamide (N-Sulfanilylbenzamide) is a sulfonamide antibacterial agent used alone or with sulfathiazole and sulfacetamide as a topical, intravaginal antibacterial preparation. |
| Cell Research | The MTT assay is used to evaluate the viability of T-47D cells incubated with different concentrations of sulfabenzamide (0.0-20 mM) or doxorubicin (0.0-0.6 μM) after 24, 48 and 72 h.(Only for Reference) |
| In vitro | Sulfabenzamide inhibits the proliferation and increases Caspase-3 activity in T-47D cells. It dose not induce apoptosis but a minimal shift from G1 to S and G2/M phases of the cell cycle[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 10 mg/mL (36.19 mM), Solution. Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 125 mg/mL (452.39 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (7.24 mM), Sonication is recommended. |
| Keywords | Sulfathiazole | Sulfacetamide | Sulfabenzamide | positive | negative | Inhibitor | inhibit | Gram | Bacterial | Autophagy | antimicrobial | Antibiotic | Antibacterial |
| Inhibitors Related | Neomycin sulfate | Aceglutamide | Hemin | D(+)-Raffinose pentahydrate | Guanidine hydrochloride | Sulfamethoxazole sodium | Terbinafine hydrochloride | Hydroxychloroquine | Hyaluronic acid sodium (MW 20 kDa) | Dimethyl sulfoxide | Sodium diacetate | Sodium bicarbonate |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Approved Drug Library | ReFRAME Related Library | Antibiotics Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $42.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
| $42.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-06-02 | |
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2025-12-01 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
| $85.00 |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2025-04-15 | ||
| $15.00 |
Wuhan wingroup Pharmaceutical Co., Ltd
|
2023-07-19 | ||
| $1.00 |
VIP7Y
|
Career Henan Chemical Co
|
2020-01-10 | |
| $59.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-05-07 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY